Numerous mutations in ANXA11 have now been described by several different groups, and may account for up to 6% of familial ALS in Chinese populations (Smith et al., 2017, Tsai et al., 2018, Zhang et al., 2018a). Here, ANXA11 is linked to amyotrophic lateral sclerosis.